In this Clinical Coffee Break, Dr. Gio Baracco discusses the latest information available about the Zika virus and what primary care providers should know in order to help protect their patients from this potentially serious infection.
Hear the latest developments in the war against antimicrobial resistance and recommendations for treating outpatient infections.
This program aims to under issues related to the changing epidemiology and challenges of treating infections caused by C. difficile, B. pertussis, and N. gonorrhoeae. It will also discuss recent changes in adult vaccination requirements.
Antimicrobial resistance in the community is a problem and requires sensible use of antibiotics. This program will review data on emerging antimicrobial resistance in outpatient practice and discuss the implications of resistance in the community. This program will also promote good antibiotic stewardship in the outpatient setting.
The ease of international travel, climate change, and emerging infections increase the risk that patients will present with febrile illnesses acquired abroad. This talk will discuss appropriate pre-travel evaluation and infection prevention counseling, as well as the appropriate early detection, evaluation, and management of the febrile traveler. The faculty will use interactive clinical vignettes to highlight the most important differential diagnoses and introduce the audience to emerging infections across the globe.
This talk will review common challenges in infectious diseases encountered in the outpatient setting. They will include clinical encounters that encompass preventive strategies, interpretation of diagnostic tests and the optimal evaluation of both undifferentiated fever and fever in the returning traveler. Finally, Dr. Sax will present the latest updates on the Zika virus epidemic and discuss the precautions to be taken by pregnant women and returning travelers from affected regions.
Dr. Sammy Saab, Professor of Medicine and Surgery at UCLA David Geffen School of Medicine, answers common questions about chronic hepatitis C infection, including which patients to screen, how to diagnose based on lab tests, and selecting an antiviral regimen based on viral genotype, exposure to prior therapy, and stage of liver disease.
Chronic Lyme disease or post-treatment Lyme disease syndrome affects about 10-20% of patients treated for Lyme disease. In this activity, learn to address some common misconceptions associated with this condition, including identifying the correct symptoms and treatments. Dr. Flaherty will take you through frequently asked questions about managing chronic Lyme disease, and discuss strategies to avoid misdiagnosis and the prescription of unnecessary antibiotics and treatments based on subjective symptoms.
Dr. Baracco addresses several common questions from primary care clinicians addressing current issues in microbial resistance in the community.
Paul Sax, Clinical Director, Division of Infectious Disease at Brigham and Women’s Hospital, Boston, reviews the latest guidelines and evidence for the diagnosis and treatment of syphilis in primary care.
Hepatitis C is the leading cause of liver transplants in the U.S. As more people are living with this disease than ever before, physicians need to familiarize themselves with the latest in diagnostics, treatment and management of hepatitis C. This activity outlines the epidemiology of the disease and details the clinical impact of chronic infection. Current treatments including the recently approved drugs are also discussed.